Last Updated: June 8, 2026

Suppliers and packagers for ETHACRYNIC ACID


✉ Email this page to a colleague

« Back to Dashboard


ETHACRYNIC ACID

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Adaptis ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 205609 ANDA Edenbridge Pharmaceuticals LLC. 42799-405-01 100 TABLET in 1 BOTTLE (42799-405-01) 2016-07-01
Agnitio ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211809 ANDA TRUPHARMA LLC 52817-367-10 100 TABLET in 1 BOTTLE (52817-367-10) 2019-09-12
Agnitio ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211809 ANDA TRUPHARMA LLC 52817-367-90 90 TABLET in 1 BOTTLE (52817-367-90) 2019-09-12
Amneal Pharms Co ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 208805 ANDA Amneal Pharmaceuticals NY LLC 69238-1126-1 100 TABLET in 1 BOTTLE (69238-1126-1) 2018-05-14
Lupin ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211719 ANDA Lupin Pharmaceuticals, Inc. 68180-159-01 100 TABLET in 1 BOTTLE (68180-159-01) 2020-02-24
Sciegen Pharms ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211232 ANDA ScieGen Pharmaceuticals Inc 50228-334-01 1000 TABLET in 1 BOTTLE (50228-334-01) 2019-08-27
Sciegen Pharms ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 211232 ANDA ScieGen Pharmaceuticals Inc 50228-334-10 100 TABLET in 1 BOTTLE (50228-334-10) 2019-08-27
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Ethacrynic Acid: Supplier Landscape for Active Pharmaceutical Ingredient (API) and Key Supply Channels

Last updated: April 26, 2026

Who supplies ethacrynic acid as an API?

Ethacrynic acid is manufactured and distributed by specialty chemical companies with pharmaceutical-grade product lines. In practice, buyers source through (1) direct API manufacturers, (2) branded generic/API distributors, and (3) contract manufacturers that sell API under their own catalog.

Typical supplier categories observed in the ethacrynic acid market

  • API manufacturers (primary supply): produce ethacrynic acid for generics and specialty injectables/orals.
  • Pharmaceutical distributors (secondary supply): stock and ship API to manufacturers and compounding channels.
  • Specialty chemical suppliers (catalog supply): sell pharmaceutical-grade variants alongside research-grade lots, subject to qualification.

Which suppliers commonly sell ethacrynic acid (API-grade) in catalog form?

The most reliable public route is via catalog listings for “ethacrynic acid” or “ethacrynic acid, USP/EP grade” sold by specialty chemical and pharmaceutical ingredient distributors. These suppliers typically present:

  • product grade (e.g., USP/EP or “pharmaceutical grade”)
  • package sizes
  • COA availability
  • quality certifications upon request
Evidence-backed examples (public catalog channels) Supplier / platform type What is sold Common buyer use Public sourcing path
Specialty chemical catalog suppliers Ethacrynic acid (often labeled “USP” or “pharmaceutical grade” in listings) Import qualification and early procurement Searchable product pages and distributor catalogs
Bulk API distributors Ethacrynic acid for drug manufacture Commercial supply to manufacturers Distributor product pages and RFQ channels
Chemical wholesalers Ethacrynic acid Repack/redistribution Wholesale catalog listings

Note: Supplier names and exact grades vary by country, lot, and regulatory status; the only robust procurement method is vendor qualification using COA, impurity profile, and regulatory documents tied to the specific lot.

What documents and quality evidence govern supplier selection for ethacrynic acid?

For ethacrynic acid, buyers typically require qualification artifacts aligned to the intended regulatory market (ANDA/MAA, local registration, or compounding).

Core procurement package

  • Certificate of Analysis (COA) with lot-specific results (assay and impurity limits)
  • Specifications (API monograph/spec plus internal acceptance criteria)
  • Quality management statement for GMP manufacture (as applicable)
  • GMP or DMF/CEP linkage (if used in the buyer’s regulatory strategy)
  • Packaging and storage specs (temperature, humidity sensitivity, labeling)

Quality benchmarks that matter to buyers

  • Assay/purity (ethacrynic acid content)
  • Related substances (impurity basket and individual thresholds)
  • Water content or residual solvent where applicable
  • Melting point / identity tests
  • Heavy metals and elemental impurities
  • Microbial limits only if the buyer’s process or regulatory pathway requires them (often not required for API-grade solids, but policy varies)

Where do procurement teams find ethacrynic acid suppliers that can support drug manufacturing?

Procurement teams typically use these channels, in this order:

  1. Regulatory-linked sources
    Look for suppliers tied to DMFs or CEPs for the API or the supplier site used in filings.
  2. GMP-certified API suppliers and contract manufacturing networks
    Source through manufacturers with documented GMP capability for APIs.
  3. Distributor networks with COA and lot traceability
    Validate with COAs and ensure consistent impurity profiles across lots.

How should buyers structure supplier due diligence for ethacrynic acid?

Because ethacrynic acid is a niche API, supply continuity risk can be higher than for high-volume APIs. Due diligence should focus on continuity and analytical consistency.

Due diligence checklist

  • Lot-to-lot impurity trend: review multiple COAs across time
  • Analytical method alignment: confirm method basis (USP/EP or validated internal methods)
  • Stability handling: verify storage conditions and packaging compatibility
  • Deviation history: request recent nonconformances related to identity, assay, or impurities
  • Supply agreement: define lead times, safety stock, and change control

What are typical lead times and packaging forms in ethacrynic acid sourcing?

These are supplier- and market-dependent, but common patterns include:

  • Packaging: sealed bags or drums with desiccant where needed; labeling to GMP/traceability needs
  • Lead time: varies by whether the supplier maintains inventory versus produces per order
  • Minimum order quantities: often higher for GMP-labeled/API-grade inventory than for research-grade

How does supplier availability differ by grade labeling (USP/EP vs “pharmaceutical grade”)?

Buyers should treat grade labels as a starting point, not a qualification outcome.

  • “USP/EP” labeled: usually means the supplier claims compliance with pharmacopeial tests, but you still must confirm specs and actual COA results.
  • “Pharmaceutical grade”: may indicate tighter controls than industrial grades but does not guarantee monograph compliance unless specified.

Who qualifies as a “real” supplier for ethacrynic acid in regulated drug production?

A supplier is practical for regulated drug production when it can provide:

  • GMP-relevant manufacturing documentation for the API production site
  • Lot traceability and consistent impurity profile
  • Regulatory dossier linkage where your application relies on it (DMF/CEP alignment)

Key Takeaways

  • Ethacrynic acid is sourced through a mix of API manufacturers, pharmaceutical distributors, and specialty chemical catalog suppliers.
  • Supplier selection depends less on the name on a webpage and more on lot-specific COAs, impurity profiles, and regulatory-grade documentation.
  • Procurement teams should prioritize suppliers that provide GMP-relevant evidence and demonstrate consistent analytical performance across lots.

FAQs

1) Is ethacrynic acid easy to source in commercial quantities?

Supply can be constrained versus mainstream APIs; qualified availability depends on vendor inventory and manufacturing cadence. Buyers reduce risk by qualifying at least two sources and requiring change control.

2) What quality documents should be requested from ethacrynic acid suppliers?

Request COAs, written API specifications, evidence of GMP manufacturing where applicable, and any dossier linkages (DMF/CEP) tied to your regulatory pathway.

3) What grade labels mean the most for ethacrynic acid?

Monograph compliance claims like “USP” or “EP” matter only when confirmed by the supplier’s specs and lot COAs. “Pharmaceutical grade” requires qualification because it may not be monograph-bound.

4) Do buyers need impurity trend data for ethacrynic acid qualification?

Yes. Ethacrynic acid quality decisions typically rely on related substances and lot-to-lot consistency, not just assay.

5) What is the fastest path to secure ethacrynic acid supply?

For regulated use, the fastest path is usually: shortlist GMP-capable vendors, request COAs and specs for multiple lots, then execute a formal qualification batch plan.


References

[1] European Pharmacopoeia. Ethacrynic acid monograph (relevant edition). Strasbourg: European Directorate for the Quality of Medicines and Healthcare (EDQM).
[2] U.S. Pharmacopeia and National Formulary (USP–NF). Ethacrynic acid monograph (relevant edition). Rockville, MD: USP.
[3] World Health Organization. Guidelines on quality control of APIs (general principles for API sourcing and quality evidence). Geneva: WHO.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.